Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB-DTK-BKV in BK Virus-Associated Hemorrhagic Cystitis Following Allo-HSCT
NCT07638332Phase 2Not yet recruiting
- Sponsor
- LucasBio
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 2 trial of LB-DTK-BKV in hemorrhagic cystitis (HC), sponsored by LucasBio. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
LB-DTK-BKV
03
Conditions
hemorrhagic cystitis (HC)
Beyond the preview
Go deeper on NCT07638332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07638332.